Clinical Trial

REAL-Fam Feasibility Study for Youth Diabetes Management

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if the REAL-Fam occupational therapy intervention is feasible to study in a larger-scale randomized controlled trial. It will also seek to understand how the intervention influences how a rural family participates in and manages their child's type 1 diabetes, their family quality of life, and the child's health outcomes. The main questions it aims to answer are: * Primary Aim 1: Evaluate the recruitment capability, participant inclusion criteria, assessment selection and process, and data. * Primary Aim 2: Evaluate the participant acceptability of and interventionist fidelity to the intervention. * Secondary Aim: Evaluate families' preliminary outcomes to the REAL-Fam on family quality of life and participation, diabetes management self-efficacy, and child blood glucose stability. Researchers will compare the REAL-Fam intervention to the Attention Group to see if there are changes in family diabetes-related health routines and psychosocial aspects of managing a child's type 1 diabetes. Participants will: * Children will wear continuous glucose monitors for study period * Caregiver participants will complete baseline and post-intervention surveys * Intervention Group: engage in 12 audio/video telehealth sessions with REAL-Fam intervention * Attention Group: engage in 3 audio/video Zoom meetings without specialized services * Complete a post-study interview
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-14
notable Primary completion pushed: 2026-06 -> 2026-12 2026-08-14
minor Completion pushed: 2026-06 -> 2026-12 2026-08-14
Trial Details
NCT Number NCT07212790
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: American Occupational Therapy Foundation, Creighton University, DexCom, Inc., University of Southern California
Conditions Type 1 Diabetes
Enrollment 16 participants
Start Date 2025-12-15
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-13